ERBB2 and cancer: Combining natural selection, gene-based pathway analysis, and other associated analysis, we proposed that the pathway was significantly associated with PCa risk, in which the mutation of EGFR, ERBB2, PTK2, RAF1, and related SNPs in the genes might be the key link in the evolution of the cancer.